Holistic Financial Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.86M Buy
19,219
+512
+3% +$106K 1.43% 17
2025
Q4
$3.86M Buy
18,707
+308
+2% +$61.5K 1.4% 16
2025
Q3
$3.3M Buy
18,399
+477
+3% +$81.2K 1.35% 18
2025
Q2
$2.89M Buy
17,922
+12,131
+209% +$1.93M 1.27% 20
2025
Q1
$985K Buy
5,791
+3,331
+135% +$579K 0.47% 29
2024
Q4
$409K Buy
+2,460
New +$420K 0.2% 63

Other funds holding FBT

Holistic Financial Partners's FBT Position: Q1 2026 in Review

Holistic Financial Partners increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 2.7% in Q1 2026, buying an estimated $106K and bringing the position to 19,219 shares worth $3.86M. The position accounts for 1.43% of the portfolio, ranked #17.

Holistic Financial Partners first reported a position in FBT in Q4 2024 and has held it in 6 quarters since. The position peaked at $3.86M in Q4 2025. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

  • Holistic Financial Partners held 19,219 shares of First Trust NYSE Arca Biotechnology Index Fund worth $3.86M as of Q1 2026.
  • Holistic Financial Partners bought 512 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $106K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 1.43% of Holistic Financial Partners's portfolio in Q1 2026, its #17 holding.
  • Holistic Financial Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2024 and has held it in 6 quarters since.
  • Holistic Financial Partners's First Trust NYSE Arca Biotechnology Index Fund position peaked at $3.86M in Q4 2025.
  • 307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Holistic Financial Partners's 13F filing for Q1 2026, filed 5 May 2026.